Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Ear nerve (auricular) stimulation to reduce blood loss during dialysis AV graft placement

Official title: Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

Run by University Surgical Vascular · NCT06647017 · Data updated 2026-11-12

This trial will try a noninvasive ear (auricular) vagus nerve stimulation device to see if it reduces blood loss in adults having dialysis AV graft placement.

More Blood Loss, Surgical trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity Surgical Vascular
Industry-sponsored
Locations1 site (Watkinsville, Georgia)
StatusRecruiting
StartedNovember 13, 2024
Main results expectedNovember 15, 2026
Study endsNovember 15, 2026
Registry record updatedMay 8, 2026
Trial IDNCT06647017 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 who are English proficient, able to give informed consent, and scheduled for dialysis AV graft (synthetic) placement are ideal candidates.

Probably not a fit

Patients with BMI ≥40, on platelet inhibitor medications, with a history of seizures or neurological disease, implanted electronic devices (e.g., pacemaker), abnormal ear anatomy or ear infection, pregnant or lactating people, or other significant comorbidities are unlikely to receive benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, sham-controlled, single-center pilot trial enrolls adults undergoing dialysis AV graft placement with a synthetic graft. Participants are randomized 1:1 to receive either 30 minutes of active transcutaneous auricular neurostimulation (tAN) or a sham device immediately before the procedure, in addition to standard surgical care. Blood loss volume and blood-based markers are measured before and during the operation to compare the two groups. The trial aims to determine whether preoperative tAN can lower intraoperative bleeding and related laboratory changes.

Why it matters

Potential benefit: If successful, the device could reduce intraoperative blood loss during AV graft placement, potentially lowering the need for transfusion and reducing surgical complications.

How similar studies have gone: Vagus nerve and transcutaneous auricular stimulation have shown effects in pain, inflammation, and other conditions, but applying tAN specifically to reduce surgical blood loss is novel with only limited preliminary support.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant is undergoing a dialysis port placement procedure using synthetic graft
* Participant is between 18 and 75 years of age
* Participant is English proficient
* Participant is able to provide informed consent and function at an intellectual level sufficient for study requirements

Exclusion Criteria:

* Participant has a BMI ≥ 40
* Participant is currently taking a platelet inhibitor medication
* Participant has a history of epileptic seizures
* Participant has a history of neurological diseases or traumatic brain injury
* Participant has presence of devices, e.g., pacemakers, cochlear prosthesis, neurostimulators
* Participant has abnormal ear anatomy or ear infection present
* Person of childbearing age, not using adequate contraception as per investigator judgment or not willing to comply with contraception for the duration of the study
* Person who is pregnant or lactating
* Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial

Where it's running

  • University Surgical Vascular
    Watkinsville, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.